INTRODUCTION
About Us
Faculty Introduction
Professor of K-NIBRT
In-kyu Kim
K-NIBRT Professor
- ikkim@yonsei.ac.kr
inkyukim0316@naver.com - 032-713-9849
- 211, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Hyun-jae Cho
K-NIBRT Professor
- rokmc@yonsei.ac.kr
- 032-713-9848
- 211, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Hongchul Yoon
K-NIBRT Professor
- hcyoon@yonsei.ac.kr
- 032-713-9853
- 212, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Jihyun Kim
K-NIBRT Professor
- kim01663@yonsei.ac.kr
- 032-713-9859
- 214, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Jiyoung Son
K-NIBRT Professor
- jyson@yonsei.ac.kr
- 032-713-9847
- 216, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Doona Song
K-NIBRT Professor
- doona.s@yonsei.ac.kr
- 032-713-9857
- 213, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
SeiMee Yoon
K-NIBRT Professor
- mahanaim84@yonsei.ac.kr
- 032-713-9856
- 213, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Sujung Lee
K-NIBRT Professor
- sujlee96@yonsei.ac.kr
- 032-713-9860
- 214, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Jaechul Lee
K-NIBRT Professor
- ljc1992@yonsei.ac.kr
- 032-713-9842
- 216, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Soonwook Hwang
K-NIBRT Professor
- hwangsw9@gmail.com
hwangsw9@yonsei.ac.kr - 032-713-9850
- 212, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Adjunct Professor of K-NIBRT
Minkyoung Kim
Professor
- hankmk@hanmail.net
Minwoo Kim
Professor
- livesby@gmail.com
Jaechoon Kim
Professor
- jckim@itp.or.kr
SunheePark
Professor
- sueniepark@biowavew.com
Insook Park
Professor
- rosapark64@naver.com
Seungyeop Baek
Professor
- sybaek@itp.or.kr
Sungae Su
CEO, Global Bio-Connection_SSP
- dragonpark1122@gmail.com
Guewha Lee
Professor
- 44star44@naver.com
June Hwang
Professor
- 99400654@daum.net
Join Appointment Professor
Jongkwang Hong
Professor
- jongkwang.hong@yonsei.ac.kr
Kim, InKyu
Professor dedicated to the project
- ikkim@yonsei.ac.kr
inkyukim0316@naver.com - 032-713-9849
- 211, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Institute
- K-NIBRT Professor
Academic background
- Kyung Hee University
- Master's Degree at Kyung Hee University Graduate School
- Doctor's Degree at Kyung Hee University Graduate School
Work experience
- 2014–2016Administrator of Ministry of Food and Drug Safety Gyeongin Branch
- 2013–2014Administrator of Director of Ministry of Food and Drug Safety Daegu Branch
- 2000–2013Director of Ministry of Food and Drug Safety
- 2000–2002Visiting scientist at the College of Pharmacy at Utah State University
- 1982–2000Korea National Institute of Health (researcher) and Ministry of Food and Drug Safety (researcher)
- 1994–1995Visiting scientist to the FDA
Acquired national pharmacist license
Acquired national oriental medicine pharmacist license
Acquired administrator’s certificate
Lecture history
- Visiting Professor, Department of Cosmetics/Songdo Bio, Incheon at Incheon Jaeneung University
- Adjunct Professor in the Department of Pharmacy/Pharmaceutical Science at Kyung Hee University
Sei Mee Yoon
K-NIBRT Professor
- mahanaim84@yonsei.ac.kr
- 032-713-9856
- 213, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Institute
- Yonsei University Professor of K-NIBRT Project
Education
- Ph. D., Integrated OMICS for Biomedical Science, Yonsei University, Seoul, Korea
- MS degree, Department of Biochemistry, Chungbuk National University, Cheongju, Korea
- Bachelor degree, Department of Food Science and Technology, Chungbuk National University, Cheongju, Korea
Experience
- 2011–2023Yonsei University, College of Pharmacy, Lab of pharmacology, Incheon, Korea
- Established of expression and purification process for cosmetic ingredient protein
- Experienced with all stages of production and purification of monoclonal antibody in CHO cells - 2006–2010 Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon, Korea
- Purification of pure proteins using various chromatography method
- Crystallization and data collection
- Determination of three-dimensional structure
Cho, Hyun Jae
K-NIBRT Professor
- rokmc@yonsei.ac.kr
- 032-713-9848
- 211, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Institute
- K-NIBRT Professor
Research field
- Fatty acid separation and purification
- Development of health functional food
- Education for Bioindustry GMP (2012-2022)
Education
- Doctor degreeNational Andong National University Biological Resources Engineering(2020.08)
Ph.D: A Study on The Health Functional Material of Purple Sweet Potato Using Bioconversion Process - Master degreeGyeongsang National University College of Bio-Environmental Engineering(2006.02)
Master's Thesis: Quality Characteristics of Chlorella-Added White Bread and soybean Curd - Bachelor Degree of Food SciencesGyeongsang National University Department of Food Science and Technology(1998.02)
Career
- 2008.11-2022.03Gyeon-buk Bio industry Research institute
- 2006.02-2008.11Dong-bu Han Nong Chemical
- 2001.05-2006.02GMF: [God Made Food]
- 1987.04-2001.05Dae-kyung Engineering
Certificate
- 2022.03Life-long educator
- 2022.01Technology Transfer Agent
- 2022.01ISO9001 14001 International judge
- 2007.106-Sigma GB Belt
- 1997.10Industrial Safety engineer
Other activities
- 1989.03-2022.05Blood donations 112th
- 2008.03-2022.03Member of Nationnal equipment introduction Deliberation Committee
- 1995.03-2022.03Marine Corps Volunteer Activities
- 2017.12Korea Heart Saver Award
Awards
- Commendation from the Minister of Health Award 2012
- Commendation from the Minister of Agriculture and Forestry Award 2017
- Food and Drug Administration Award 2007
- National Agricultural Cooperative Federration Award 2019
- National equipment Utilization Portal Supporter Award 2017
Research publications
- 2021.03GMP that bioindustry majors must know 11
- 2021.03Cell culture experiment handbook for functional material development
- 2018.10Research and development of soy sauce using 100% shiitake mushrooms with excellent anticancer activity
- 2016.10Development of foods that facilitate bowel movements using purple sweet potatoes
Patent
- 2017.03Oriental melon grain syrup with contains ginger and manufacturing method
- 2022.0Grain powder composition with good solubility in the mouth
- 2018.10Research and development of soy sauce using 100% shiitake mushrooms with excellent anticancer activity
Ji Hyeong Kim
K-NIBRT Professor
- jihyeong.kim@yonsei.ac.kr
- 032-713-9862
- 215, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Institute
- Professor at K-NIBRT, Yonsei University
Academic background
- Bachelor's Degree at Dankook University
- Master's Degree at Dankook University
Work experience
- 2023–presentProfessor at K-NIBRT, Yonsei University
- 2022-2022KDDF, Korea Drug Development Fund
- 2021-2022Consultant at Delver, Inc.
- 2017-2021Hanmi Pharmaceutical, Co., Ltd.
- 2016-2017YD Diagnostics, Corp.
- 2016-2016ISU ABXIS, Co., Ltd.
- 2015-2016KOPRI, Korea Polar Research Institute
Books & Publications
- 2023.01Biopharmaceutical job bible by job specialist, Letuin Books
Research Field
- PQS, Pharmaceutical Quality System
- Quality Management System
- Risk Management
- Regulatory Affair
- Data Integrity
- Validation Qualification
- Education Training
- Inspection Audit
- Quality Control
Doona Song
K-NIBRT Professor
- doona.s@yonsei.ac.kr
- 032-713-9857
- 213, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Education
- Bachelor's degree in Biotechnology, Yonsei University
- Ph.D. in Biotechnology, Yonsei University
Professional Experience
- 2021-2023Visiting Professor, College of Pharmacy, Yonsei University ( Specializing in the Graduate Program for Pharmaceutical Industry Cooperation, with a focus on new drug research)
- 2020-2021Senior Researcher, STU Bio (Research and Development, Pharmaceutical Synthesis)
- 2019-2019Lecturer, School of Dentistry, Yonsei University (Organic Chemistry)
- 2016-2019Research Manager, Industry-Academia Cooperation Office, Yonsei University (Successfully secured projects for nurturing future scholars)
- 2013-2020Postdoctoral Researcher, Industry-Academia Cooperation Office, Yonsei University (Engaged in pharmaceutical design and synthesis across various research projects in the Molecular Pharmacology Laboratory)
Major Research Achievements
- Optimization techniques for leading compounds
- AI-based research on new drug design
- In silico/in vitro studies for ADME optimization of small molecules
Participation in Research Projects
- Production and properties study of anti-HIV candidate substances targeting HIV-NC
- Design and synthesis of novel small molecules inducing functional regulation of bone marrow-derived mesenchymal stem cells for cardiovascular disease treatment
- Construction of a library of inhibitors targeting human Leucyl-tRNA synthetase and development of anticancer agents
- Chemical biology research on the effects of small molecules regulating the function of the ion exchange channel pendrin for congenital deafness and hypertension treatment
- Investigation of the pharmacological characteristics of small molecules inhibiting the function of the ion exchange channel pendrin for congenital deafness treatment (Research Fellow Project)
- Development of a PDS correction agent for congenital deafness treatment
- Optimization study for KCNQ4 activators for the development of a therapy for noise-induced hearing loss.
Technology Transfer
- 2021Research collaboration and license agreement (연세의료원-아보메드)
Research Paper
- 2023Structural optimization of novel Ras modulator for treatment of Colorectal cancer by promoting β-catenin and Ras degradation
- 2022Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer
- 2022Indirubin-3′-alkoxime derivatives for upregulation of Wnt signaling through dual inhibition of GSK-3β and the CXXC5-Dvl interaction
- 2021Structure-based modification of pyrazolone derivatives to inhibit mTORC1 by targeting the leucyl-tRNA synthetase-RagD interaction
- 2020Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury
- 2020PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation
- 2020Identification and Validation of VEGFR2 Kinase as a Target of Voacangine by a Systematic Combination of DARTS and MSI biomolecules
- 2019Novel pendrin inhibitor attenuates airway hyperresponsiveness and mucin expression in experimental murine asthma
- 2017Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators
- 20152-(Trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34+ haematopoietic stem cells
- 2013New synthetic aliphatic sulfonamido-quaternary ammonium salts as anticancer chemotherapeutic agents
- 2011, 2013Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy
- 2010Structure Based Optimization of Chromen-Based TNF-alpha Converting Enzyme (TACE) Inhibitors on S1' Pocket and Their Quantitative Structure Activity Relationship (QSAR) Study
Patents
- Composition and method for the prevention or treatment of respiratory diseases
- Novel rodanin derivatives, their manufacturing method, and pharmaceutical compositions for AIDS prevention or treatment containing them as active ingredients
- Novel diamine compounds or pharmaceutically acceptable salts thereof, their manufacturing method, and pharmaceutical compositions for cancer treatment containing them
- Novel thio- or urea derivatives, their manufacturing method, and pharmaceutical compositions for AIDS prevention or treatment containing them as active ingredients
- Preparation of diamine derivatives as anticancer agents
Myeong Jun Oh
K-NIBRT Professor
- kdoh@yonsei.ac.kr
- 032-713-9861
- 215, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Education
- Ph.D., University of Virginia, U.S.A
NIH Biotechnology Training Program Fellow - M.S.E., University of Pennsylvania, U.S.A
KOSEF Graduate Student Scholarship - O.C.S., Officer Candidate School, Navy
- B.S., Sungkyunkwan University
Professional Experience
- 2023-presentProfessor, K-NIBRT
- 2020-2022Chief Research Scientist, Bioneer
- 2016-2020Technical and Scientific Advisor, Prime4Dia
- 2014-2016Assistant Professor, King Saud University, Saudi Arabia
- 2014Senior Researcher, Sungkyunkwan University
- 2009-2013Training Fellow, NIH Biotechnology Training Program, U.S.A.
- 2011Visiting Scholar, Georgia Institute of Technology, U.S.A
- 2006-2008Researcher, Korea Institute of Industrial Technolog
Jae Chul Lee
K-NIBRT Professor
- ljc1992@yonsei.ac.kr
- 032-713-9842
- 216, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
EDUCATION
- 2022.09-2024.08Ph.D degree in pharmaceutics, Dongguk university
- 2017.03-2019.02Master’s degree in pharmaceutics, Dongguk university
- 2011.03-2017.02Bachelor’s degree in biological sciences, Dankook university
WORK EXPERIENCE
- 2022.09-2023.08Lecturer, pharmacy, Dongguk university
Major Research Achievements
- Pre-formulation & Formulation
- Lyophilization process
Hongchul Yoon
K-NIBRT Professor
- hcyoon@yonsei.ac.kr
- 032-713-9853
- 212, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
EDUCATION
- 2011Yonsei University, Department of Biotechnology, Republic of Korea Ph.D. in Medicinal chemistry
- 1996Korea University, Department of Biotechnology, Republic of Korea M.S. in Biochemistry
- 1994Korea University, Department of Biotechnology, Republic of Korea B.S. in Biotechnology
Major Research Achievements
- 2023–2024Yunovia Pharm. Managing Director, Head of Innovative Solution Group
- 2016–2023Ildong Pharma. Managing Director, Head of Innovative Solution Group
- 2012–2016CalIBR(California Institute for Biomedical Research, CA, US) Research Scientist
- 1996–2012Daewoong Pharma. Research fellow, Department of Drug discovery
Research Paper(last 3-years only)
- 2023Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease. Journal of Medicinal Chemistry (ACS publicatin
- 2023Discovery of ID110521156, a Small Molecule GLP-1 Receptor Agonist, for the Treatment of Type 2 Diabetes and Obesity. ADA 83th Scientific sessions poster (American Diabetes association)
- 2022Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine- Induced Dry Eye Mice. International Journals of Molecular Sciences (MDPI)
- 2021Discovery of 5-(N-hydroxy carbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Bioorganic & Medicinal Chemistry Letters (Elsevier)
Patents(last 3-years PCT only)
- WO 2024/085661A1Novel triheterocyclic compounds
- WO 2024/063576A1Novel quinazoline compound as KRAS inhibitor
- WO 2024/063578A1Novel tetraheterocycle compound
- WO 2024/019541A1Heteroaryl derivative compound and use thereof
- WO 2024/014885A1Novel Bicyclic heteroaryl compound and use thereof
- WO 2023/182869A1Novel salt of GLP-1receptor agonist compound, preparation method thereof and pharmaceutical composition thereof
- WO 2023/113474A1Novel salt of1-sulfonyl pyrrole derivative, Method for preparing same, and Pharmaceutical composition including same
- WO 2023/113458A1Novel salt of1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical comprising thereof
- WO 2023/067388A1Uses of CFTR modulatorand/or PDE4 inhibitor compounds
- WO 2022/231357A1Pharmaceutical comprising GPR40 agonist and SGLT-2 inhibitor
- WO 2022/195522A1Inhibitors of ANO6 and their uses thereof
- WO 2022/157686A1Inhibitors of Anoctamin6 protein and their uses thereof
- WO 2022/123319A1Biased agonists of opioid receptors
- WO 2022/084741A1CFTR modulator compounds, compositions, and uses thereof
Ji hyun Kim
K-NIBRT Professor
- kim01663@yonsei.ac.kr
- 032-713-9859
- 214, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
EDUCATION
- 2002.03-2005.08B.S., Department of Life Sciences, Korea University
- 2006.03-2013.08Ph.D., Department of Life Sciences, POSTECH
- 2013.09-2016.02Post-doctoral associate, Department of Life Science, POSTECH
- 2017.03-2018.06Research Scientist, Rosetta Exosome Inc.
- 2021.11-2024.07Post-doctoral associate, Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota
Minwoo Kim
Professor
- livesby@gmail.com
- -
- -
Education
- B.Sc. in Microbiology, Chungbuk National University
- Master's in Public Health(M.P.H), Graduate School of Public Health, Yonsei University
Professional Experience
- 2020–presentDirector, Quality Services APAC, Merck Life Science
- 2015–2020QA Manager, Bristol Myers Squibb
- 2013–2015Quality & Compliance Supervisor, Janssen Korea
- 2010–2013QC team lead, LG Life Sciences
- 2007–2010Hanmi Fine Chemical
Kim Jae-choon
Professor
- jckim@itp.or.kr
- -
- -
Education
- 1991Jeonju Sangsan High School
- 2000Bachelor of Engineering, Food Engineering Woosuk University
- 2003Master of Biotechnology, Sejong Graduate School
- 2016Ph.D. of Biotechnology Sejong Graduate School
Professional Experience
- 2021.02-presentIncheon TP Chief Researcher Bioprocess Human Resource Development Center (Center Construction and Equipment Establishment)
- 2016.01-2021.02Binex Corporation General Manager Cultivation Team (Biopharmaceutical Production: 200 ~ 1000 L)
- 2010.11-2016.12Binex Corporation Team Leader (R&D CenterDevelopment and Technology Transfer of Animal Cell Culture Processes)
- 2007.07-2010.06BioR&D Senior Researcher (Research Institute (Development and Technology Transfer of Cultivation Processes))
- 2003.11-2004.04Aprogen Co., Ltd Researcher Research Institute (Cell Line Development)
- 2010.03-2010.08Nazarene University Instructor (lecture)
- 2007.09-2008.08Sejong University Instructor (lecture)
Research Paper - Master
- ANovel Cell Culture System Developed for High Density Culture of Anchorage Dependent and Anchorage Independent Cells
Research Paper - Ph.D
- Production of Therapeutic Recombinant Proteins byCultivation of rCHO Cells in a Depth Filter Perfusion sustem anda Single-Use Pneumatic Bioreactor Syustem
- Ⅰ: Evaluation of a novel pneumatic bioreactor system for culture of recombinant Chinese hamster ovary cells. (Biotechnology and Bioprocess Engineering, 2013, vol.18, no.4,)
- Ⅱ: Producrtion of recombiniant human growth hormone by rCHO cells in a depth filter perfusion system. (Biotechnology and Bioprocess Engineering, 2014,vol.19, no.6,)
Sunhee Park
Professor
- sueniepark@biowavew.com
- -
- -
Education
- Ph.D. in Microbiology, Washington State University
- M.S. in Microbiology, Seoul National University
- B.S. in Biology, Sogang University
Professional Experience
- Member, WHO Coronavirus Vaccine Evaluation PWG
- Ombudsman, Korea Health Industry Development Institute (KHIDI) R&D
- Adjunct Lecturer, KNIBRT Biopharmaceutical Program (participated in ADB and WHO talent training programs, lectures, and practical training, 2022)
- Legal Director, Korean Society for Microbiome
- Committee Member, Catholic University Industry-Academic Cooperation Foundation
- Committee Member, Ministry of Food and Drug Safety (MFDS) in various divisions, including Vaccines/Blood Products, Cell and Gene Therapy, GMP, and Microbiome
- 2019.04-presentCEO, BioWave W
- 2020-2021Senior Advisor, SINEK Inc.
- 2018.03-2019.08Full-time Professor, Hallym University Industry-Academic Cooperation Foundation
- 2016.02-2021.02Head of Global Expansion Support Division, MFDS Bio-Pharmaceutical Association Dynamic Bio Program
- 2013.10-2018.02Vice President/Head of Research Institute, EuBiologics and Adbiotech Co., Ltd.
- 1999.07-2013.09Director of Analysis Center, MFDS (Jul. 1999 – Sep. 2013), overseeing vaccine, viral product, blood product divisions, among others
- 1987.05-1999.07Senior Researcher & Director, KRIBB and KIST, specializing in virus and oncology research
Awards & Honors
- Order of Science and Technology Merit (2003, Virus Immunology Research)
- Minister of Health and Welfare Award (2013, Excellence in MFDS Operations)
- Commissioner’s Award, MFDS (2017, WHO PQ vaccine registration, UNICEF supply contributions)
- Commissioner’s Award, MFDS (2018, Bio-Industry Strategic Planning Committee Leadership)
- Director’s Award, MFDS Biopharmaceuticals Bureau (2019, Global Expansion Support Leadership)
- 1st Contribution Award, Center for Women in Science, Engineering and Technology (2013)
- 1st Contribution Award, EuBiologics Co., Ltd. (2016)
International Experience
- Listed in Who’s Who in the World (2011–2014)
- Coordinator for Korea-U.S. FDA NCTR/NITR MOU and Joint Symposiums (2007 & 2008)
- Coordinator for Korea-Japan NIHS/NITR Joint Symposium, Tokyo
- Expert Committee Member, WHO EAP Biostandards (2005–2009)
- OECD/IPCS Toxicogenomics Program Advisor (2006–2008)
- OECD Molecular Screening & Toxicogenomics Program Advisor (2008–), Chair of Epigenetics Division
- Board Member, International Papillomavirus Society (2004–2014)
Domestic Activities
- Head of Global Expansion Support Division, Dynamic Bio Program, MFDS (2016–2021)
- WHO Committee Member, MFDS Bio-Industry Development Strategy Task Force (2016–Present)
- Legal Director, Korean Society for Microbiome (2018–Present)
- Member, National Center for Science & Technology Diplomacy (2017)
- Central Pharmaceutical Review Committee Member, MFDS (2014)
- Expert Advisor, Korea Disease Control and Prevention Agency (2013)
- Adjunct Professor at Sungkyunkwan University (2014–2021), Korea University (2003–2013), Sogang University (2001–2003), and Hallym University
Publications & Notable Contributions
- Authored over 150 research papers and multiple books
- Currently engaged in supporting development projects involving coronavirus vaccines, CAR-T therapies, antibody immuno-oncology drugs, microbiome pharmaceuticals, and general oncology drugs
In-Sook Park
Professor
- rosapark64@naver.com
- -
- -
Education
- 1987Bachelor of Pharmacy, Yeungnam University
- 1989Master of Pharmacy, Graduate School, Yeungnam University
- 1999Doctor of Pharmacy, Graduate School, Chungbuk University
- 2010Master of Social Pharmacy, Sookmyung Women's University Graduate School of Clinical Pharmacology
Professional Experience
- 22.12.30 ~ presentKorea Center for Regulatory Science Center Director General (BioHealth Regulatory Science Project )
- 20.03.30. ~ 22.12.20.Director General of the Biopharmaceuticals and Herbal Medicine Evaluation Department, National Institute of Food and Drug Safety Evaluation (NIFDS), Ministry of Food and Drug Safety(MFDS), overseeing the approval review and national marketing authorization of biopharmaceuticals such as vaccines, antibody therapies, and cell therapies
- 18.02.06. ~ 20.03.29.Director of Research Planning and Coordination Division, National Institute of Food and Drug Safety Evaluation (NIFDS), Ministry of Food and Drug Safety(MFDS), overseeing the planning and management of R&D
- 15.11.09. ~ 18.02.05Director of the Dental and Gastroenterological Device Division, National Institute of Food and Drug Safety Evaluation (NIFDS), Ministry of Food and Drug Safety(MFDS), responsible for medical device approval evaluation
- 11.01.05. ~ 15.11.08Director Pharmaceutical Standardization Division, National Institute of Food and Drug Safety Evaluation (NIFDS), Ministry of Food and Drug Safety(MFDS), responsible for pharmaceutical approval evaluation
Research Paper - Master
- Interaction between Histamine Antagonists and Muscarinic Receptors (II) (Effects on Muscarinic Receptors in the Brain)
Research Paper - Ph.D
- The Effect of NMDA Receptor Antagonists on 5-Hydroxytryptamine-Induced Mouse Head-Twitch Response
Seungyeop Baek
Professor
- sybaek@itp.or.kr
- -
- -
Education
- 2013. 08 – 2020.08 Ph.DBiotechnology Yonsei University, Republic of Korea Supervisor: Prof. YoungSoo Kim Prof. Gyounghee-Han Prof. Jun-Seok Lee
- 2010. 08 – 2013. 03 M.S.Brain and Cognitive Engineering Korea University, Republic of Korea Supervisor: Prof. Seong-Whan Lee
- 2002. 02 – 2008. 03 B.S.Bio-resources Science Dankook University, Republic of Korea Supervisor: Prof. Dae-Kyung Kang
Employment history
- 2008 - 2008National Institute of Agricultural Sciences Department of Agricultural Environment / Researcher
- 2009 - 2010Korea Institute of Science and Technology Center for Water Cycle Research / Researcher
- 2010 - 2010Seoul National University Hospital Department of Clinical Pharmacology / Researcher
- 2010 - 2013Korea university Pattern Recognition and Machine Learning Lab, Department of Brain & Cognitive engineering / Researcher
- 2013 - 2018 Korea Institute of Science and Technology Diagnosis, Treatment of Care System of Dementia / Researcher
- 2020 - 2021Yonsei university Laboratory of Chemical Biology, Department of Pharmacy / Post-doctor researcher
- 2021 ~ PresentIncheon Technopark Bioprocessing Technology Training Center / Senior researcher
- 2022 ~ PresentYonsei University K-NIBRT Project / Adjunct Professor
- 2023 ~ PresentIncheon Technopark Biocenter / Senior researcher
Publication list
- 1. Soo Min Cho, Sejin Lee, Seung-Hoon Yang, Hye Yun Kim, Michael Jisoo Lee, Hyunjin Vincent Kim, Jiyoon Kim, Seungyeop Baek, Jin Yun, Dohee Kim, Yun Kyung Kim, Yakdol Cho, Jiwan Woo, Tae Song Kim & YoungSoo Kim. (2016) Age-dependent inverse correlations in CSF and plasma amyloid-β(1–42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice. Scientific Reports
- 2. Seung-Hoon Yang, Dongkeun Kenneth Lee, Jisu Shin, Sejin Lee, Seungyeop Baek, Jiyoon Kim, Hoyong Jung, Jung-Mi Hah & YoungSoo Kim. (2016) Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice. EMBO molecular Medicine
SungAe Su
CEO, Global Bio-Connection_SSP
- dragonpark1122@gmail.com
- -
- -
Education
- Ph. D., The Rutgers University, New Brunswick, New Jersey, U.S.A.
- Master of Art, University of Northern Iowa, Cedar Falls, Iowa, U.S.A.
- Bachelor of Pharmacy, College of Pharmacy, Ewha Womans University, Seoul, Korea
Professional Experience
- Global Bio-Connection_SSP, Korea and USA (2019-Present): CEO
- Korea Biotechnology Industry Organization: Seoul, Korea (2019-Present): Advisor (Advisor)
- Samsung Bioepis, Drug Product Team, Inchon, Korea (2017-2019): Senior Advisor (Senior Advisor)
- Amgen Inc., Drug Product Development, Thousand Oaks, CA, USA (1996-2017): Principal Scientist
- R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ, USA (1981-1996): Scientist
- Seoul National University Hospital, Seoul, Korea: Korean Registered Pharmacist
Awards and Honors
- CE Pharm Award 2010 from the international meeting of CE Pharm (2010)
- Several Amgen Bravo Acclaim awards, 3-star, 2-star, 1-star
- Amgen Development Hall of Fame Award (2002)
- Corporate Quality ACES Awards (2006, 2007)
Professional Contributions and Accomplishments
- Associate Director of an International CA Separation Science Society (CASSS)
- Organization committee member for Latin America Capillary Electrophoresis (LACE) and CE Pharm meeting (1999-Present)
- Co-Chair for CE Pharm meeting (2001, 2003, 2004, 2006)
- Member of American Chemical Society
- Invited speaker for LACE (2006)
- Invited speaker for Pittsburg Conference (2007)
- Invited speaker for Asia Pacific Pharmaceutical Congress: Therapeutic Protein development and production (2008)
- Invited speaker for Beckman Coulter and Dionex seminar series (2002, 2004)
- Invited speaker for CE Pharm meeting (1999, 2002, 2005, 2007)
- Authored 3 book chapters
- 16 publications in peer reviewed journal
LEE, GUEWHA
Professor
- 44star44@naver.com
- -
- -
Education
- 1996Bachelor's degree in Biological Engineering from Inha University
- 1998Master's degree in Biological Engineering from Inha University.
- 2004Ph.D. in Biological Engineering from Inha University.
Professional Experience
- 2021.11.~presentHead of R&D Headquarters at Hu evergreen pharm (Director) (Overall R&D Management)
- 2015.04.~2021.09.Principal Researcher in the Innovative CAR-T GMP center at AbClon (Responsible for GMP Manufacturing, Head of Manufacturing Process Team)
- 2009.10.~2014.12.Senior Researcher in the Process Development Team at Procell Therapeutics (Team Leader for Process Development)
- 2004.03.~2009.09.Senior Researcher in the NK Cell Therapy Team and Protein Engineering Team at Mogam Biotechnology Research Institute (Cell Cultivation and Analysis)
Research Paper - Master
- Process Studies for Enhancement of 10-DAB Production in Taxus Cell Suspension Culture
Research Paper - Ph.D
- Studies of recombinant Leukotactin-1 on Protection of Hematopoietic Stem and Progenitor Cells from Cytotoxicity of Cancer Therapy
Soonwook Hwang
K-NIBRT Professor
- hwangsw9@gmail.com
hwangsw9@yonsei.ac.kr - 032-713-9850
- 212, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
Education
- 1987 Bachelor's degree in Biotechnology from Dongguk University.
- 1990 Master's degree in Biotechnology from Dongguk University Graduate School.
- 2002 Ph.D. in Biotechnology from Kangwon National University Graduate School.
Professional Experience
- 2022 Completed Health and Social Policy Course at Seoul National University Graduate School of Public Health
- 2021~2022 Committee Member of the Pharmaceuticals Specialty Committee, Ministry of Food and Drug Safety
- 2021 Director of Industry Promotion at the Korea Health Industry Development Institute
- 2020 Director of International Healthcare at the Korea Health Industry Development Institute
- 2019 Director of the Seoul Biohub Center at the Korea Health Industry Development Institute
- 2016~2018 Head of the Pharmaceutical and Bio-industry Division at the Korea Health Industry Development Institute
- 2017 Planner at the Medium to Long-term Strategy Planning Division for the Pharmaceutical Industry, Ministry of Health and Welfare
- 2017~2022Committee Member of the Internal Regulatory Review Committee, Ministry of Food and Drug Safety
Jong Kwang Hong
Professor
- jongkwang.hong@yonsei.ac.kr
- -
- -
Education
- 2009. Sep – 2014. FebKorea Advanced Institute of Science and Technology, Daejeon, Korea Ph.D degree in Biological Sciences
- 2003. Mar–2005. FebKorea Advanced Institute of Science and Technology, Daejeon, Korea Master's degree in Biological Sciences
- 1996. Mar-2003. FebYonsei University, Seoul, Korea Bachelor's degree in Biotechnology
Representative career
- 2021. Sep-CurrentK-NIBRT Education Center, Songdo, Korea Joint Professor
- 2020. Mar-CurrentYonsei University, Wonju, Korea Division of Biological Science and Technology Assistant Professor
- 2018. May-2020.JanBioprocessing Technology Institute (BTI) at A*STAR and National University of Singapore (NUS), Singapore Systems biology group Research Scientist
- 2005. Jan-2015. JanBiopharmaceutical companies (LG Chem, Hanwha Chemical, Aprogen) Research topics:
1.Production cell line development (Target protein: mAbs, BsAb and Fc-fusion protein)
2.Early-stage & Late-stage cell culture process development
Research area
- Data-driven and model-guided cell culture media design
- Transient gene expression platform (cell lines, media, and reagents)
- Continuous biomanufacturing (real-time monitoring, media optimization)
- Optimization of large-scale production using computational fluid dynamics
- Digital twin of bioprocessing using CFD, PAT, and in silico modeling
kim min kyoung
Professor
- hankmk@hanmail.net
- -
- -
Education
- Major in Life Sciences, Ewha Womans University
- Tumor Immunology, Seoul National University College of Medicine
Research career
- Senior Researcher, National Designated Tumor Immunology Research Center (TIMRC), Seoul National University College of Medicine
- Principal Researcher, National Designated Digestive Efficacy Evaluation Center (NCEED), Inha University College of Medicine
- Research Professor, Inha University College of Medicine
- Adjunct Professor, K-NIBRT Yonsei University
Seung Tae-Baek
Professor
- back1980@itp.or.kr
- -
- 84, Songdomunhwa-ro 84beon-gil,Yeonsu-gu, Incheon, South Korea 21986
Education
- 2025 Bachelor of Engineering / Academic Credit Bank
- 2005 Associate degree / Dongyang Mirae University
Work Experience
- 2023. 07 ~ Present Incheon Technopark Bio Center
- 2015. 11 ~ 2023. 07 Bi-nex Engineering Team
- 2010. 12 ~ 2015. 11 Okong Facilities Management Department
License and Certificate
- 2024 Maintenance of facilities
- 2015 Industrica Engineer Electricity
- 2012 Industrica Engineer Craftsman Air-Conditioning and Refrigerating Machinery
- 2012 Completion of Max Capa expert training course through facility improvement(Korea Standards Association)
- 2012 Completion of the fair safety report evaluation curriculum
(Korea Occupational Safety and Health Agency) - 2011 Finished training course for refrigeration and refrigeration machine manufacturing facilities and inspection institution
(Korea Gas Safety Corporation) - 2008 Completion of the Electrical Basic Course of the Small and Medium Business Training Institute
- 2008 Completion of Hydraulic Basic Course at Small and Medium Business Training Institute
June Hwang
Professor
- 99400654@daum.net
- -
- -
Education
- Bachelor of Science in Biotechnology, Inha University, 2008
- Master of Science (M.S.) in Bioengineering, Seoul National University, 2011
경력
- 2023 – Present Consultant, Merck, Consulting APAC Viral Vector Technology - Global Focused Modality
- 2021 – 2023 Consultant, Merck, Global Upstream Integrated Systems, Mixing, System Field Services, USP Bio Continuous Processing Go-to-Market Strategy Lead, APAC Single-Use Go-to-Market Strategy Lead - Global Strategy Deployment
- 2019 – 2020 Senior Technology Manager, Merck, Technology Consulting for TFF, Clarification, and Cell & Gene Therapy Processes, Global Go-to-Market Lead for Clarification, Cell & Gene Therapy Champion
- 2015 – 2019 Technology Manager, Merck, Technology Consulting for TFF, Clarification, Vaccines, and Viral Gene Therapy Processes, APAC Go-to-Market Lead for Clarification
- 2013 – 2015 Field Marketing Specialist, Merck, Technology Consulting for TFF, Clarification, and Virus Removal
- 2010 – 2013 Research Scientist, ISU ABXIS, Downstream Process Development and Technology Transfer for Monoclonal Antibodies (mAbs) and Recombinant Proteins
Master’s Thesis
- Characterization of β2-Microglobulin Amyloid Formation Depending on pH
Published Papers
- Risk Assessment for Biopharmaceutical Single-Use Manufacturing: A Case Study of Upstream Continuous Processing, Biologicals, 84 (2023) 101713
JEON JAE HYUK
Professor
- jjh0209@itp.or.kr
- -
- -
Education
- 2024 Phd student, School of Inha University, Biological Sciences and Bioengineering
- 2015 MS, Soonchunhyang University, Marine Biotechnology
- 2009 BS, Soonchunhyang University, Marine Biotechnology
EMPLOYMENT EXPERIENCE
- 2023 Employer C: Bio Center, Incheon Technopark, Senior Researcher
- 2021 Employer B: Plasma Fractionation Center, Korean Red Cross, Researcher
- 2017 Employer A: National Marine Biodiversity Institute of Korea, Junior Researcher
Jiyoung Son
K-NIBRT Professor
- jyson@yonsei.ac.kr
- 032-713-9847
- 216, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
EDUCATION
- 2015-2021 Ph.D Pharmacy. CHA University Graduate School
- 2000-2003 M.S Dairy Science. Chungnam National University Graduate School
- 1994-1999 B.S. Dairy Science. Chungnam National University
EMPLOYMENT HISTORY
- 2025-CurrentK-NIBRT Professor
- 2021-2024Enbios Inc.
- 2020-2021AmicogenPharma Inc.
- 2015-2018Pharmaresearch BIO Inc.
- 2012-2014Hanwhapharmaceutics Inc.
- 2007-2012Aprogen
- 1999-2006DB Group Inc.
RESEARCH ACTIVITY
GRANTS
-
Date : 07/01/2021 – 06/30/2023
Project title : Developing multiple anticancer drugs (platform) with efficacy / non-toxicity / persistence -
Date : 04/01/2022 – 12/31/2023
Project title : Development and standardization of green algae-derived immune-based atopy improvement substances -
Date : 05/01/2023 – 12/31/2023
Project title : Development and commercialization of atopic dermatitis treatment material from black bamboo leaves -
Date : 11/01/2021 – 10/31/2023
Project title : Development of thrombolytic therapy or multi-modal treatment for ischemic stroke -
Date : 04/01/2018 – 12/31/2020
Project title : Development of an oral treatment for age related macular degeneration by using YSB201 for the approval of clinical phase 1 -
Date : 04/01/2017 – 12/31/2019
Project title : Development of functional food materials using sea squirt-derived vanadium -
Date : 01/01/2018 –12/31/2018
Project title : Development of functional new food substances for body fat reduction and analysis -
Date : 05/15/2014 – 11/30/2016
Project title : Research on the advancement for Standards and Specifications of Biological products -
Date : 04/01/2008 – 03/31/2012
Project title : Structural and Functional Studies on Cell Membrane Proteome of Human Mesenchymal Stem Cells
Sujung Lee
K-NIBRT Professor
- sujlee96@yonsei.ac.kr
- 032-713-9860
- 214, Bioprocessing Technology Training Center, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea
EDUCATION
- 2000 Ph.D in Pharmaceutics, Ewha Womans University
- 1990 MS in Pharmaceutics, Ewha Womans University
- 1988 BS. in Pharmacy, Ewha Womans University
Professional Experience
- 2024 Professor at Graduate School of Pharmaceutical Bioindustry, Dongguk University
- 2020~2023 Member of Pharmaceutical Reimbursement Evaluation Committee, Health Insurance Review & Assessment Service
- 2012~2013 Member of Cancer Review Committee, Health Insurance Review & Assessment Service
- 1991~2023 Ministry of Food and Drug Safety (MFDS) in various roles (Director for Drug Safety Evaluation Division, Director for Drug Quality Division, Director for Approval Management Office, Administrator of Gwangju Regional Office)